Navigation Links
Thermal Gradient Announces Manufacture of Next Generation DNA Testing Device
Date:6/26/2012

ROCHESTER, N.Y., June 26, 2012 /PRNewswire/ -- Thermal Gradient, Inc., a developer of disposable ultra-fast DNA testing devices, announced today that it has initiated the manufacture of its next generation device.  Robert Juncosa, the company's Chief Technology Officer stated, "Our previous generation device was a huge success.  It performs PCR, the critical step in almost all DNA tests, in less than eight minutes.  This new device is capable of "real-time" PCR, a process used to determine the amount of initial DNA being tested.  This is very important when testing for infectious diseases like HIV."

Because of design improvements over the previous generation, the new device will is expected to perform better but will cost less to manufacture.

"Our recent breakthroughs and this new device position us as the premier technology for both point of care and high throughput clinical laboratory testing," says CEO Joel Grover.  "Because of our speed, low cost, and fundamental design, the hardware module required to perform a quantitative DNA test is small. This makes it easily scalable to achieve high throughput systems in a modest instrument footprint."

The company will begin testing the new devices in the third quarter.  Dr. Grover added, "When our internal testing is complete, we will then make cartridges and demonstration platforms available to diagnostic systems developers for their evaluation and assay optimization."  

About Thermal Gradient
Thermal Gradient develops devices and systems based on its patented technology that enables nucleic acid testing to be performed in minutes instead of an hour or more.  Systems based on this technology can be developed for clinics and remote settings as well as for main-line diagnostic platforms for the clinical laboratory.  For more information, please visit:
www.thermalgradient.com

Contact:
Joel Grover, Ph.D
Chief Executive Officer
Thermal Gradient, Inc.
585-248-9598
info@thermalgradient.com

 


'/>"/>
SOURCE Thermal Gradient
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
2. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
3. ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product
4. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
5. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
6. ERT Announces Stockholder Approval of Merger
7. Biodel Announces $18.5 Million Private Placement
8. BioElectronics Corporation Announces Indian Distributors Ecommerce Website
9. Marken Announces Global Advisory Board
10. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
11. Generex Announces Results of Annual Stockholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... 2016  CVS Health, the nation,s largest pharmacy innovation ... score of 100 percent on the Corporate Equality Index ... an annual national benchmarking survey and report on corporate ... the Human Rights Campaign Foundation. "Our ... colleagues, customers and suppliers bring to CVS Health," said ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 /PRNewswire/ ... announced preliminary safety and efficacy data from a ... selective MDM2 inhibitor, suggesting that DS-3032 may be ... acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome ... of the phase 1 study of DS-3032 were presented ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... The Avamere Family ... – Avamere Transitional Care of Puget Sound ; located at 630 S ... center will provide patients recovering from illness or injury with intensive skilled nursing ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... Researchers at ... on the growing brains of young athletes. Over the course of three years, researchers ... through unique mouth guards. The mouth guards, equipped with special sensors, will track the ...
(Date:12/5/2016)... Fla (PRWEB) , ... December 05, 2016 , ... ... as Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus ... announcement, PER® president, Phil Talamo said, “We are honored to have Amy E. ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one of New York ... participated in the 36th Annual Cutting Edge Aesthetic Symposium at the Waldorf Astoria in ... that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for his expertise in ...
(Date:12/5/2016)... and MALVERN, PA (PRWEB) , ... ... ... Supplies Management ("CSM"), a Great Point Partners ("GPP") portfolio company, today announced ... – Clinical Supplies ("TCS"). TCS was previously a subsidiary of Chiltern ...
Breaking Medicine News(10 mins):